Bafna Pharmaceuticals set to consider new issue of share warrants: The Board of Bafna Pharmaceuticals has withdrawn its entire preferential issue of 40 lakh share warrants, as one of the investors was ineligible to be involved in share dealings for a time period, causing delays in the process.

The Board is now set to meet on Jan 7 to consider a fresh issue of 80 lakh share warrants to promoters and non-promoters, and also explore other options to raise funds.